Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI.
about
Minocycline Attenuates Neonatal Germinal-Matrix-Hemorrhage-Induced Neuroinflammation and Brain Edema by Activating Cannabinoid Receptor 2CB1 and CB2 Cannabinoid Receptor Antagonists Prevent Minocycline-Induced Neuroprotection Following Traumatic Brain Injury in MiceInvestigation of cross-species translatability of pharmacological MRI in awake nonhuman primate - a buprenorphine challenge studyA systematic review of physiological methods in rodent pharmacological MRI studies.CNS animal fMRI in pain and analgesia.Fatty acid amide hydrolase (FAAH) inhibitors exert pharmacological effects, but lack antinociceptive efficacy in rats with neuropathic spinal cord injury pain.Brain CB₂ Receptors: Implications for Neuropsychiatric Disorders.Brain cannabinoid CB₂ receptors modulate cocaine's actions in micePharmacologic magnetic resonance imaging (phMRI): imaging drug action in the brain.Chronic blockade of cannabinoid CB2 receptors induces anxiolytic-like actions associated with alterations in GABA(A) receptors.Commentary: Functional Neuronal CB2 Cannabinoid Receptors in the CNSTolerance to chronic delta-9-tetrahydrocannabinol (Δ⁹-THC) in rhesus macaques infected with simian immunodeficiency virusCentrally mediated antinociceptive effects of cannabinoid receptor ligands in rat models of nociception.Functional MRI in conscious rats using a chronically implanted surface coil.Comparing the Effects of Isoflurane and Alpha Chloralose upon Mouse PhysiologyCNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity.Synthesis and Biological Evaluation of Thiophene-Based Cannabinoid Receptor Type 2 Radiotracers for PET Imaging.Dynamic regulation of the endocannabinoid system: implications for analgesia.Synthesis and Preliminary Evaluation of a 2-Oxoquinoline Carboxylic Acid Derivative for PET Imaging the Cannabinoid Type 2 Receptor.Crosstalk between fibroblasts and inflammatory cells.The Role of Cannabinoid Receptors in the Descending Modulation of Pain.Combination Chemistry: Structure-Activity Relationships of Novel Psychoactive Cannabinoids.The role of dimethylarginine dimethylaminohydrolase in idiopathic pulmonary fibrosis.MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models.Antiaversive effects of cannabinoids: is the periaqueductal gray involved?Changes in interleukin-1 signal modulators induced by 3,4-methylenedioxymethamphetamine (MDMA): regulation by CB2 receptors and implications for neurotoxicity.Regulation of Fas receptor/Fas-associated protein with death domain apoptotic complex and associated signalling systems by cannabinoid receptors in the mouse brain.Evidence for a novel functional role of cannabinoid CB(2) receptors in the thalamus of neuropathic rats.CB2 cannabinoid receptors: new vistas.Roles of high-mobility group box 1 and thrombin in murine pulmonary fibrosis and the therapeutic potential of thrombomodulin.System-specific activity in response to Δ9 -tetrahydrocannabinol: a functional magnetic resonance imaging study in awake male rats.Pharmacological MRI response to a selective dopamine transporter inhibitor, GBR12909, in awake and anesthetized rats.'Macrophage' cannabinoid receptor goes up in smoke.Identification of three cannabimimetic indazole and pyrazole derivatives, APINACA 2H-indazole analogue, AMPPPCA, and 5F-AMPPPCA.Identification of two new-type designer drugs, piperazine derivative MT-45 (I-C6) and synthetic peptide Noopept (GVS-111), with synthetic cannabinoid A-834735, cathinone derivative 4-methoxy-α-PVP, and phenethylamine derivative 4-methylbuphedrine fr
P2860
Q28109502-A45C595A-1C59-48E0-9B50-DBA6B62D50CAQ28315817-446C934B-66DE-44BF-A6B4-8E0D0E167BAEQ28543992-7BD54971-A644-4C45-B12B-EF443D9DCDD9Q30420324-DCF4ED6A-E2EC-4BE3-9357-B453C222D085Q30469133-6CEABA8E-8143-4350-AF1C-81242CF2DAECQ33560467-85A8E0BA-3509-4035-A1C5-9BD92B8D1B63Q33664105-A614B009-6AFE-4832-9D95-9B897B8916FEQ34203193-50A0EE0C-6D9B-4CEF-A7D9-CB18898C3E16Q34229087-EF4C461B-A4CC-4140-93BF-282401884815Q34631608-E182912A-CA51-4823-842C-50944ED4A2D0Q35107820-3843CA0F-C108-4DCF-A0D1-F28C8D85328EQ35119113-08C800EC-2A90-4909-8296-9D244BCD2AD0Q35421957-934AA12A-2E3F-416B-BF4F-9B7C79535DAAQ35847764-07C2ACDF-A34F-499E-B7CD-41A1516D0082Q36009366-C3738B83-E22D-47AF-9732-54DA5CEF667EQ36071533-AAECF560-B4B9-4A06-B021-172102CC03A2Q37127657-E52FC3F1-1198-4E4F-BC8E-37AEEFA55C6FQ37611106-ECACB5A7-1922-4D7B-959A-90CC19B0B851Q37689804-893DE741-C20D-4017-9995-AD6BE30C3D06Q38204265-C286D14D-A860-4B83-AA15-85CAC588F0F5Q38974429-F807B38E-9517-4D2A-A114-741141FF9CC1Q38983634-EF4CDDF3-0944-45E3-B252-2D9CC912BFA0Q39523831-66FA09AC-CAC0-42EA-A40E-9440B0867D89Q41139755-89E6BB8B-347A-47B0-90A8-C58C74472A8AQ41351855-C741D5B7-57CD-4BBA-A7C9-1F99F311CDAAQ41885785-26987DCA-8453-4D38-A31F-766256712F76Q42102522-49C017DC-B140-4716-891D-0E08C7BF2E9DQ42217054-0BA4031C-D7B0-4462-8BBC-407C97A0A6F0Q45854330-5905340C-12B3-412C-9435-836511988A9CQ47322392-B362920A-E31C-459C-A3A4-F0D9A9ACF9EBQ47591946-FD2CAFB1-909A-499C-9BFF-6BBD9C4BB8BAQ47758791-5A56A7F6-A106-4048-8E9C-6AA1C086B8C1Q48234903-CC8BB647-2CBB-472F-87C0-52A98D8C0F19Q53152322-F9343684-A44B-441C-84AA-5811017DEE91Q56689548-9183F0A8-127C-4509-94DA-8F5FE6F3344A
P2860
Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Differential effects of cannab ...... vity using pharmacological MRI
@nl
Differential effects of cannab ...... ity using pharmacological MRI.
@ast
Differential effects of cannab ...... ity using pharmacological MRI.
@en
type
label
Differential effects of cannab ...... vity using pharmacological MRI
@nl
Differential effects of cannab ...... ity using pharmacological MRI.
@ast
Differential effects of cannab ...... ity using pharmacological MRI.
@en
prefLabel
Differential effects of cannab ...... vity using pharmacological MRI
@nl
Differential effects of cannab ...... ity using pharmacological MRI.
@ast
Differential effects of cannab ...... ity using pharmacological MRI.
@en
P2093
P2860
P921
P3181
P356
P1476
Differential effects of cannab ...... vity using pharmacological MRI
@en
P2093
A E Tovcimak
P2860
P304
P3181
P356
10.1038/SJ.BJP.0707506
P407
P577
2007-10-29T00:00:00Z